Related Experiment Video
Updated: Aug 19, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Use of stimulant medications in children
1University of Illinois College of Medicine, Peoria.
Insights
A systematic approach is crucial for treating attention deficit disorder (ADD) with stimulant medications. Diagnosis confirmation and counseling on medication use, actions, and side effects are essential before starting treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Pediatrics
Background:
- Attention deficit disorder (ADD) often co-occurs with learning difficulties.
- Stimulant medications are commonly used in ADD management.
- A structured approach to medication use is necessary.
Purpose of the Study:
- To outline a systematic approach for using stimulant medications in ADD treatment.
- To emphasize the importance of accurate diagnosis and patient counseling.
- To guide healthcare providers in discussing treatment alternatives.
Main Methods:
- Systematic review of treatment protocols.
- Analysis of diagnostic criteria for ADD.
- Guidelines for patient and parent counseling on stimulant therapy.
Main Results:
- Accurate diagnosis of ADD is a prerequisite for initiating drug therapy.
- Comprehensive counseling regarding medication actions and side effects is vital.
- Informed decision-making involves discussing various treatment options.
Conclusions:
- A systematic, evidence-based approach enhances stimulant medication efficacy in ADD.
- Parental counseling and confirmed diagnosis are critical components of successful treatment.
- Understanding medication profiles and alternatives optimizes patient outcomes.
Abstract:
A systematic approach to the use of stimulant medications is required in the treatment of attention deficit disorder and associated learning problems. The diagnosis of attention deficit disorder must be confirmed before drug therapy is started, and parents must be counseled about the use of stimulant medications. The actions and side effects of the various treatment alternatives should be discussed.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.